Skip to main content
Premium Trial:

Request an Annual Quote

Visible Genetics Puts Itself on the Block; Future Uncertain

For an updated version of this article, click here.


NEW YORK, May 30 - Visible Genetics said today it is looking to sell itself.


The company said that a sale would "include a modest premium" to its current share price. Shares in the Toronto-based tool company closed at $3.75 on the Nasdaq yesterday. Its current market cap hovers around $65 million.


"While VGI is committed to acting in the best interest of its shareholders, the timing and outcome of this process is uncertain," the company said.


The decision by Visible Genetics has caused it to postpone a conference call scheduled for this morning.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.